Kathryn DiMarco
Comptroller/Controller/Auditor at ORGANON & CO.
Net worth: 386 267 $ as of 2024-04-29
Profile
Kathryn DiMarco is currently the Senior Vice President-Finance & Controller at Organon & Co. Prior to this, she worked as the Controller at Allergan Ltd.
(Ireland) from 2015 to 2020 and as the International Controller at Merck Sharp & Dohme Corp.
from 2014 to 2015.
She obtained her undergraduate degree from Lehigh University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ORGANON & CO.
0.01% | 2024-05-03 | 20,970 ( 0.01% ) | 386 267 $ | 2024-04-29 |
Kathryn DiMarco active positions
| Companies | Position | Start |
|---|---|---|
| ORGANON & CO. | Comptroller/Controller/Auditor | 2021-06-01 |
Former positions of Kathryn DiMarco
| Companies | Position | End |
|---|---|---|
| ALLERGAN PLC | Comptroller/Controller/Auditor | 2019-12-31 |
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Comptroller/Controller/Auditor | 2014-12-31 |
Training of Kathryn DiMarco
| Lehigh University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| Organon & Co. | |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Health Technology |
- Stock Market
- Insiders
- Kathryn DiMarco
